GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,448.00p
   
  • Change Today:
      22.50p
  • 52 Week High: 1,774.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,100.23m
  • Volume: 7,237,685
  • Market Cap: £59,371m
  • RiskGrade: 129
  • Beta: 0.00

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
30-Apr-25 Shore Capital Buy 1,483.50p - - Reiteration
28-Mar-25 JP Morgan Cazenove Underweight 1,488.50p - - Reiteration
29-Nov-24 Berenberg Bank Buy 1,335.00p 1,820.00p 1,600.00p Reiteration
03-Sep-24 Deutsche Buy 1,655.00p - 1,850.00p Reiteration
05-Jul-24 Citigroup Buy 1,511.00p 2,120.00p 1,900.00p Reiteration
27-Jun-24 Jefferies Buy 1,526.00p - 2,100.00p Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,448.00p
Change Today 22.50p
% Change 1.58 %
52 Week High 1,774.50p
52 Week Low 1,264.00p
Volume 7,237,685
Shares Issued 4,100.23m
Market Cap £59,371m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 27-May-2025

Time Volume / Share Price
16:05 0 @ 1,451.00p
16:01 1 @ 1,452.00p
15:52 1 @ 1,454.00p
15:13 5 @ 1,452.50p
14:56 10 @ 1,453.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page